ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

In Brief: Cancer Act Extension, Training Bill Breezing Through Congress; Army Causes Ft. Detrick Flap

July 5, 1974

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999